A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists

被引：0
|
作者：
Cassandra M. Townsend
Reena Khanna
Aze Suzanne Wilson
机构：
[1] Western University,Division of Gastroenterology, Department of Medicine
[2] Western University,Division of Clinical Pharmacology, Department of Medicine
[3] Western University,Department of Physiology and Pharmacology
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Ulcerative colitis; Crohn’s disease; Inflammatory bowel disease; Tumor necrosis factor-; antagonists; Non-melanoma skin cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4436 / 4440
页数：4
相关论文
共 50 条
  • [1] A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists
    Townsend, Cassandra M.
    Khanna, Reena
    Wilson, Aze Suzanne
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (12) : 4436 - 4440
  • [2] Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease
    Andersen, Nynne Nyboe
    Pasternak, Bjorn
    Basit, Saima
    Andersson, Mikael
    Svanstrom, Henrik
    Caspersen, Sarah
    Munkholm, Pia
    Hviid, Anders
    Jess, Tine
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (23): : 2406 - 2413
  • [3] Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
    Long, Millie D.
    Herfarth, Hans H.
    Pipkin, Clare A.
    Porter, Carol Q.
    Sandler, Robert S.
    Kappelman, Michael D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (03) : 268 - 274
  • [4] Melanoma and non-Melanoma Skin Cancer in Inflammatory Bowel Disease Patients following Tumor Necrosis Factor-α Inhibitor Monotherapy and in Combination with Thiopurines: Analysis of the Food and Drug Administration Adverse Event Reporting System
    McKenna, Michael R.
    Stobaugh, Derrick J.
    Deepak, Parakkal
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (03) : 267 - 271
  • [5] SCREENING FOR MELANOMA AND NON-MELANOMA SKIN CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A TERTIARY CARE HOSPITAL
    Tageldin, Omar
    Zelman, Sara
    Parsa, Nour A.
    Mansoor, Muhammad S.
    Batool, Asra
    GASTROENTEROLOGY, 2020, 158 (06) : S422 - S422
  • [6] No Increased Risk of Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease Using Thiopurines
    van Schaik, Fiona D.
    Smeets, Hugo M.
    van der Heijden, Geert J.
    Siersema, Peter D.
    van Oijen, Martijn G.
    Oldenburg, Bas
    GASTROENTEROLOGY, 2011, 140 (05) : S770 - S771
  • [7] Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease
    Subramaniam, Kavitha
    Pavli, Paul
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) : 193 - 194
  • [8] Drug insight:: Antagonists of tumor-necrosis factor-α in the treatment of inflammatory bowel disease
    Chang, JT
    Lichtenstein, GR
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (04): : 220 - 228
  • [9] Drug Insight: antagonists of tumor-necrosis factor-α in the treatment of inflammatory bowel disease
    John T Chang
    Gary R Lichtenstein
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 220 - 228
  • [10] Recurrence of Non-melanoma Skin Cancer in Inflammatory Bowel Disease Patients Who Continue Thiopurines After Developing Incident Non-melanoma Skin Cancer While on a Thiopurine
    Shah, Yash
    Trivedi, Chinmay
    Khan, Nabeel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S327 - S327
12345